Weight and length at birth and risk of early-onset prostate cancer (United States)

被引:14
作者
Boland, LL
Mink, PJ
Bushhouse, SA
Folsom, AR
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA
[2] Exponent Hlth Grp, Washington, DC USA
[3] Minnesota Dept Hlth, Minnesota Canc Surveillance Syst, Minneapolis, MN USA
关键词
birth length; birth weight; prostate cancer;
D O I
10.1023/A:1023930318066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: A case-control study was conducted to examine the association of weight and length at birth with early-onset prostate cancer. Methods: Cases of prostate cancer diagnosed between 1988 and 1995 (n = 192) were identified through the Minnesota Cancer Surveillance System. Two separate control groups were selected using driver's license (DL) and birth certificate (BC) listings. Results: Using the DL control group, an inverse association was observed between birth weight and prostate cancer risk; adjusted odds ratios (95% confidence intervals) for less than or equal to3000, 3001-3500, 3501-4000, and > 4000 g at birth were 1.0, 0.72 (0.40-1.28), 0.58 (0.31-1.10), and 0.49 (0.24-1.00). In analyses using the BC control group, adjusted odds ratios (95% CIs) for the aforementioned birth weight categories were 1.0, 1.18 (0.64-2.18), 0.80 (0.42-1.54), and 1.04 (0.48-2.26), respectively. For both control groups, adjusted odds ratios were somewhat elevated for the upper three categories of birth length, but all confidence intervals included the null value. Conclusions: These findings do not support the hypothesis that greater weight or length at birth increases risk of prostate cancer.
引用
收藏
页码:335 / 338
页数:4
相关论文
共 12 条
[1]  
CARUCCI PM, 1979, NEW YORK STATE DEP H, V15, P1
[2]   Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies [J].
Eaton, NE ;
Reeves, GK ;
Appleby, PN ;
Key, TJ .
BRITISH JOURNAL OF CANCER, 1999, 80 (07) :930-934
[3]  
Ekbom A, 2000, CANCER EPIDEM BIOMAR, V9, P221
[4]   Perinatal characteristics in relation to incidence of and mortality from prostate cancer [J].
Ekbom, A ;
Hsieh, CC ;
Lipworth, L ;
Wolk, A ;
Ponten, J ;
Adami, HO ;
Trichopoulos, D .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 313 (7053) :337-341
[5]   Prostate cancer: a comprehensive review [J].
Pentyala, SN ;
Lee, J ;
Hsieh, K ;
Waltzer, WC ;
Trocchia, A ;
Musacchia, L ;
Rebecchi, MJ ;
Khan, SA .
MEDICAL ONCOLOGY, 2000, 17 (02) :85-105
[6]  
Petridou E, 1990, Epidemiology, V1, P247, DOI 10.1097/00001648-199005000-00011
[7]   VALIDATION OF 1989 TENNESSEE BIRTH CERTIFICATES USING MATERNAL AND NEWBORN HOSPITAL RECORDS [J].
PIPER, JM ;
MITCHEL, EF ;
SNOWDEN, M ;
HALL, C ;
ADAMS, M ;
TAYLOR, P .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (07) :758-768
[8]  
Platz EA, 1998, AM J EPIDEMIOL, V147, P1140
[9]  
Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345
[10]   DO DIET AND ANDROGENS ALTER PROSTATE-CANCER RISK VIA A COMMON ETIOLOGIC PATHWAY [J].
ROSS, RK ;
HENDERSON, BE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (04) :252-254